Short interest for Ashford gives investors a sense of the degree to which investors are betting on the decline of Ashford's stock. Short interest data is updated every two weeks.

Ashford Stock (AMEX:AINC), Short Interest Report

Ashford

Ashford Inc is a provider of asset management and advisory services to other entities, within the hospitality industry. The company's operating segments include Advisory, Remington, Premier, INSPIRE, RED and OpenKey, and Corporate and Other. It generates maximum revenue from the Remington segment. INSPIRE segment provides event technology and creative communications solutions services. The Advisory segment provides asset management and advisory services to other entities. Its Remington segment provides hotel management services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Mexico and All other countries.

Long Ideas

News

Penny Stocks

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

AINC

Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.

Insiders Buying Ashford And 1 Other Stock

Price Target

Small Cap

Analyst Ratings

ALLT

AVGO

HOOD

URBN

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Broadcom To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Friday

Hotel,Sign,With,Stars,,3d,Illustration

REIT

Real Estate

CLDT

Equity Fund Buys Hersha Hospitality Trust: Hotel REITs Go Wild

Ashford Inc. (Holding Company) Common Stock

Ashford Inc

Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#39;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Ashford </h3>
<ul>
<li>The Trade: Ashford Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ainc#NYSE">AINC</a>) CEO and Chairman of the Board Monty J Bennett <a href="https://www.benzinga.com/quote/WBA/analyst-ratings"> acquired a total of 200,000 shares </a> an average price of $4.91. To acquire these shares, it cost around $982,000.</li>
<li>What&rsquo;s Happening: On April 1, the company announced it approved a reverse stock split and delisting strategy.</li>
<li>What Ashford Does: Ashford Inc is a provider of asset management and advisory services to other entities, within the hospitality industry.</li>
</ul>
<h3>Kingsway Financial Services </h3>
<ul>
<li>The Trade: Kingsway Financial Services Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kfs#NYSE">KFS</a>) President and CEO John Taylor Maloney Fitzgerald acquired a total of 296 shares at an average price of $8.44. To acquire these shares, it cost around $2,498. The company&rsquo;s CFO and EVP Kent A Hansen also purchased 185 shares.</li>
<li>What&rsquo;s Happening: On March 22, Kingsway Financial Services entered into a one year extension of its existing share repurchase program.</li>
<li>What Kingsway Financial Services Does: Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States.</li>
</ul>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/04/38284954/abbott-laboratories-u-s-bancorp-and-3-stocks-to-watch-heading-into-wednesday"> Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday </a>

AINC: 89% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/38044948">Ashford shares are trading higher. The company announced it approved a reverse stock split and delisting strategy.</a>
PIK: 100% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/38045093">Kidpik shares are trading higher after the company entered a merger agreement with Nina Footwear.</a>
ACOR: -77% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/38045188">Acorda Therapeutics shares are trading lower after the company commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.</a>

Movers

ACOR

Market-Moving News for April 2nd

WIIM

Ashford shares are trading higher. The company announced it approved a reverse stock split and delisting strategy.

Ashford is taking these steps to avoid the substantial cost and expense of being a public reporting company and to focus the Company&#39;s resources on enhancing long-term stockholder value. The Company anticipates savings exceeding&nbsp;$2,500,000&nbsp;on an annual basis as a result of the Proposed Transaction.

Reported Earlier, Ashford's Board Approves Reverse Stock Split And Delisting Strategy To Focus On Enhancing Shareholder Value

Ashford Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AINC#NYSE">AINC</a>) ("Ashford" or the "Company") today announced that the NYSE American LLC (the "NYSE American") has accepted the Company's plan of compliance for continued listing on the exchange.
As previously reported, on December&nbsp;20,&nbsp;2023, the Company received notification (the "Letter") from the NYSE American that it was not in compliance with the continued listing standards set forth in the NYSE American Company Guide (the "Company Guide"). Specifically, the Letter indicated that the Company was not in compliance with Sections 1003(a)(i) and 1003(a)(ii) of the Company Guide, requiring a listed company to have stockholders' equity of (i) at least $2.0 million if it has reported losses from continuing operations or net losses in two of its three most recent fiscal years and (ii) at least $4.0 million if it has reported losses from continuing operations or net losses in three of its four most recent fiscal years. The Letter noted that the Company reported a stockholders' deficit of $295.7 million as of September&nbsp;30,&nbsp;2023, and has had losses from continuing operations and/or net losses in three of its four most recent fiscal years ended December&nbsp;31,&nbsp;2022.
The Company was required to submit a plan to the NYSE American by January&nbsp;19,&nbsp;2024 addressing how it intends to regain compliance with Sections 1003(a)(i) and (ii) of the Company Guide by June&nbsp;20,&nbsp;2025, or sooner if the NYSE American determines that the nature and circumstances of the Company's continued listing status warrant a shorter period of time. The Company submitted a plan prior to the deadline.
On February&nbsp;27,&nbsp;2024, the Company received notice from the NYSE American that it had accepted the Company's plan and granted a plan period through June&nbsp;20,&nbsp;2025. During the plan period the Company will be subject to quarterly review to determine if it is making progress consistent with the plan. If the Company does not regain compliance with the NYSE American listing standards by June&nbsp;20,&nbsp;2025, or if the Company does not make sufficient progress consistent with its plan, then the NYSE American may initiate delisting proceedings.
The Company's stock will continue to be listed on the NYSE American during the plan period pursuant to an extension. The Company's receipt of such notification from the NYSE American does not affect the Company's business, operations or reporting requirements with the U.S. Securities and Exchange Commission.
The Company can provide no assurances that it will be able to make progress with respect to its plan that NYSE American will determine to be satisfactory, that it will regain compliance with Section 1003(a)(i) and (ii) of the Company Guide on or before the expiration of the plan period, or that developments and events occurring subsequent to the Company's formulation of the plan or its acceptance by the NYSE American will not adversely affect the Company's ability to make sufficient progress and/or regain compliance with Section 1003(a)(i) and (ii) of the Company Guide on or before the expiration of the plan period or result in the Company's failure to be in compliance with other NYSE American continued listing standards.
Ashford is an alternative asset management company with a portfolio of strategic operating businesses that provides global asset management, investment management and related services to the real estate and hospitality sectors.

Ashford Announces Acceptance Of Compliance Plan By NYSE American

Ashford (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AINC#AMEX">AINC</a>) reported quarterly earnings of $1.02 per share. This is a 38.18 percent decrease over earnings of $1.65 per share from the same period last year. The company reported quarterly sales of $206.81 million which beat the analyst consensus estimate of $187.90 million by 10.07 percent. This is a 15.92 percent increase over sales of $178.41 million the same period last year.

Earnings

Ashford Q4 Adj EPS $1.02 Down From $1.65 YoY, Sales $206.81M Beat $187.90M Estimate

ABUS

ACIC

ACIW

ADSK

AKLI

AMRN

AMWD

ANIP

ARGX

ARLO

AVPT

BBWI

BIRK

BLFS

BRFH

CAPR

CCOI

CDRO

CELH

CERT

CMPS

CMRX

COMM

CPSI

CRAI

CRDF

CRON

CUBE

CVEO

DAVA

DELL

DHIL

DMTK

DOLE

DOUG

ESAB

ESTC

EVLV

EVRG

EVRI

EXLS

FDUS

FIHL

FREY

FSCO

GDEN

GDRX

GECC

GLNG

GOLF

GOVX

GRBK

HAYW

HYFM

IHRT

INSW

INUV

ITRN

JAKK

KPTI

LSEA

LSTA

Melco Resorts & Entertainment Limited - American Depositary Shares

MLCO

MNTX

MPLN

NBBK

Earnings Scheduled For February 29, 2024

Ashford (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AINC#AMEX">AINC</a>) is set to give its latest quarterly earnings report on Thursday, 2024-02-29. Here's what investors need to know before the announcement.
Analysts estimate that Ashford will report an earnings per share (EPS) of $0.00. 
Ashford bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.65, which was followed by a 1.35% drop in the share price the next day.
Here's a look at Ashford's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.61</td>
<td>1.73</td>
<td>1.34</td>
<td>1.16</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.96</td>
<td>1.57</td>
<td>1.67</td>
<td>1.65</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>2.0%</td>
<td>3.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1709150501_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Ashford were trading at $2.58 as of February 27. Over the last 52-week period, shares are down 80.0%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/AINC/earnings">To track all earnings releases for Ashford visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Ashford's Earnings Outlook

Ashford Inc Receives Letter Of Non-Compliance From NYSE American

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="http://benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Keybanc raised Broadcom Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avgo#NASDAQ">AVGO</a>) price target from $1,000 to $1,200. Keybanc analyst John Vinh maintained an Overweight rating. Broadcom shares fell 0.9% to close at $972.00 on Wednesday. <a href="https://www.benzinga.com/quote/AVGO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank increased the price target for HUTCHMED (China) Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcm#NASDAQ">HCM</a>) from $20 to $22.1. Deutsche Bank analyst Cyrus Ng upgraded the stock from Hold to Buy. HUTCHMED shares rose 0.4% to close at $18.24 on Wednesday. <a href="https://www.benzinga.com/quote/HCM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham slashed Allot Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/allt#NASDAQ">ALLT</a>) price target from $4 to $2.5. Needham analyst Alex Henderson maintained a Buy rating. Allot shares closed at $1.36 on Wednesday. <a href="https://www.benzinga.com/quote/ALLT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup cut the price target for LexinFintech Holdings Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lx#NASDAQ">LX</a>) from $3.86 to $2.12. Citigroup analyst Judy Zhang downgraded the stock from Buy to Neutral. LexinFintech shares gained 3.4% to $2.11 in pre-market trading. <a href="https://www.benzinga.com/quote/LX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley cut the price target for American Eagle Outfitters, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aeo#NYSE">AEO</a>) from $14 to $13. Morgan Stanley analyst Kimberly Greenberger maintained an Underweight rating. American Eagle shares rose 0.7% to $16.90 in pre-market trading. <a href="https://www.benzinga.com/quote/AEO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Oppenheimer slashed Ashford Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ainc#NYSE">AINC</a>) price target from $17 to $14. Oppenheimer analyst Tyler Batory maintained an Outperform rating. Ashford shares gained 3.1% to close at $5.34 on Wednesday. <a href="https://www.benzinga.com/quote/AINC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley lowered Robinhood Markets, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hood#NASDAQ">HOOD</a>) price target from $12 to $11. Morgan Stanley analyst Michael Cyprys maintained an Equal-Weight rating. Robinhood shares rose 0.2% to $8.23 in pre-market trading. <a href="https://www.benzinga.com/quote/HOOD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities cut the price target for Companhia Energ&eacute;tica de Minas Gerais - CEMIG (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cig#NYSE">CIG</a>) from $3.2 to $2.6. B of A Securities analyst Arthur Pereira downgraded the stock from Buy to Neutral. Companhia Energ&eacute;tica de Minas Gerais shares fell 4.8% to $2.17 in pre-market trading. <a href="https://www.benzinga.com/quote/CIG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley cut Urban Outfitters, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/urbn#NASDAQ">URBN</a>) price target from $42 to $36. Morgan Stanley analyst Alex Straton downgraded the stock from Overweight to Equal-Weight. Urban Outfitters shares fell 1.1% to $31.46 in pre-market trading. <a href="https://www.benzinga.com/quote/URBN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HSBC raised Linde plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lin#NASDAQ">LIN</a>) price target from $440 to $447. HSBC analyst Martin Evans maintained a Buy rating. Linde shares fell 0.1% to close at $411.62 on Wednesday. <a href="https://www.benzinga.com/quote/LIN/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
&nbsp;
Check This Out: <a href="https://www.benzinga.com/news/earnings/23/11/35936455/walmart-best-buy-and-3-stocks-to-watch-heading-into-friday"> Walmart, Best Buy And 3 Stocks To Watch Heading Into Friday </a>

Oppenheimer analyst Tyler Batory maintains Ashford (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AINC#AMEX">AINC</a>) with a Outperform and lowers the price target from $17 to $14.

Oppenheimer Maintains Outperform on Ashford, Lowers Price Target to $14

Wall Street reporters have a phrase to describe stocks that rise when another stock of the same sector reports excellent news. They write, "Other stocks rose in sympathy." These so-called sympathy stocks don't have any of their own news to propel them higher, but investors surmise that if one stock of a sector reports good news, others of the same ilk may soon follow suit. The result is investors buying shares and pushing the sympathy stock prices higher.
This is especially true when a company is acquired by or merges with another company. Merger fever takes over, and investors then speculate on which companies from the same sector may be next to be purchased at a price well above present levels.
An entire real estate investment trust (REIT) subsector recently rose in sympathy when one of its lower-priced companies was acquired at a substantial premium.
Hersha Hospitality Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HT#NYSE">HT</a>) is a Harrisburg, Pennsylvania-based hotel REIT that owns 25 luxury and lifestyle hotels with 3,811 rooms in larger cities across the U.S.&nbsp;&nbsp;
On Aug. 28, Hersha Hospitality Trust announced it will merge with KSL Capital Partners. Under the terms of the agreement, KSL Capital Partners will acquire all outstanding common shares of Hersha Hospitality for $10 per share in an all-cash transaction of $1.4 billion. This is a 60% premium over Hersha Hospitality's closing price on Aug. 25.
KSL Capital Partners is a private equity fund that invests in the hospitality, recreation, real estate and travel service sectors. It was founded and originally called KSL Recreation in 1992. KSL Capital Partners was formed in 2005, and since then it has invested in over 150 businesses across North America, Europe, Asia and Australia.
Upon announcing the merger, Hersha Hospitality's Executive Chairman Jay H. Shah said, "This transaction provides our shareholders with immediate and certain value at a substantial premium to our public valuation."
Hersha Hospitality stock stormed up 55.89% on the news and closed at $9.79, with most of that gain coming right at the opening bell.  The news triggered buying on several other hotel REITs as well. At the end of the day, five of the best 12 REIT performances were hotel REITs. Take a look at three of them.
<h2 class="wp-block-heading">Don&#8217;t miss:</h2>
<ul>
<li>A REIT you've probably never heard of is up 36% over the past two years. <a href="https://www.benzinga.com/real-estate/reit/23/07/33427501/this-reit-youve-never-heard-of-is-crushing-the-market-up-36-over-the-past-two-years">Here's how its unique model is crushing the market.&nbsp;</a></li>
<li>This REIT just teamed up with the company that built Elon Musk's tiny house to develop affordable housing communities. <a href="https://www.benzinga.com/alternative-investments/listing/future-of-housing-fund">Here's how you can be among the first to buy shares.</a></li>
</ul>
Braemar Hotels &amp; Resorts Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHR#NYSE">BHR</a>) is a Dallas-based REIT that invests in luxury hotels and resorts across the U.S. and in Puerto Rico. Braemar Hotels &amp; Resorts now has investments in 16 properties with 4,184 rooms.
On Aug. 2, Braemar Hotels &amp; Resorts reported mixed second-quarter operating results. Funds from operations (FFO) of $0.20 per share was in line with estimates, but 45.95% below FFO of $0.37 per share in the second quarter of 2022. However, revenue of $186.71 million beat the consensus estimate of $173.87 million and was a 6.76% increase over revenue of $174.89 million in the second quarter of 2022.
On Aug. 14, B. Riley Securities analyst Bryan Maher downgraded Braemar Hotels &amp; Resorts from Buy to Neutral and lowered the price target from $7 to $3.50.&nbsp;
"As it relates to Braemar's luxury resort hotels, we have been writing about RevPAR (revenue per available room) weakening for several quarters," Maher noted.&nbsp;
Following the news on Hersha Hospitality, Braemar Hotels soared 15.57% in one day.
Ashford Hospitality Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHT#NYSE">AHT</a>) is another Dallas-based hotel REIT that owns 100 hotels with 22,316 rooms across 26 states. It focuses on upscale full-service and select-service hotels. Ashford Hospitality Trust is externally advised by Ashford Inc. (NYSEAMERICAN: AINC).
Ashford Hospitality was one of the worst-performing REITs throughout 2022, with a total return of negative 56.73%. Year to date it has continued to perform poorly, with a total return of negative 30.72%.
On July 10, Ashford Hospitality announced it will surrender ownership of 19 hotels across the U.S. as a means to halt worsening debt. Ashford Hospitality ceased making mortgage payments on two hotels in Newark, New Jersey, one in Oakland, California, and one in Walnut Creek, California. Ashford Hospitality estimates it will save $700 million by not paying these mortgages and then paying down debt on other mortgages.&nbsp;
But on Aug. 2, Ashford Hospitality announced second-quarter FFO of $0.78, beating the consensus estimates by $0.31. Revenue of $375.75 million also beat the Street estimates by $5.72 million and was 7.9% higher than revenue during the second quarter of 2022. RevPAR for all hotels was up 6.7% from the second quarter of 2022 to $144.25.
Following Hersha Hospitality's announcement, Ashford Hospitality was up 10.29% on the day.
Chatham Lodging Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLDT#NYSE">CLDT</a>) is a West Palm Beach, Florida-based hotel REIT that owns 39 upscale extended-stay hotels with 5,914 rooms across 16 states and Washington, D.C. Its portfolio includes Residence Inn by Marriott and Homewood Suites by Hilton.
On Aug. 2, Chatham Lodging Trust reported its second-quarter operating results. Adjusted funds from operations (AFFO) of $0.43 per share beat the estimate of $0.39 by 10.26% and was above AFFO of $0.41 per share from the second quarter of 2022. Revenue of $84.48 million beat the estimate of $84.06 and was 3.32% above revenue of $81.76 million in the second quarter of 2022. RevPar has improved from $157 to $189 over the past seven months.
Despite a year-to-date loss of over 13%, on the heels of Hersha Hospitality's announcement, Chatham Lodging rose 6.19% on the day.
Other Hotel REITs with notable sympathy price changes were Summit Hotel Properties Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INN#NYSE">INN</a>), up 6.07%, Xenia Hotels &amp; Resorts Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHR#NYSE">XHR</a>), up 5.75%, and Diamondrock Hospitality Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRH#NYSE">DRH</a>), up 5.2%.
Hotel REITs have struggled since early 2020 when COVID-19 first hit the U.S. The growing popularity of Airbnb, Vrbo and other short-term rental properties have put a dent in hotel REIT earnings, especially in a post-COVID era of consumer wariness.
On July 20, analyst Tylor Batory of Oppenheimer &amp; Co. Inc. downgraded Chatham Lodging Trust, along with Braemar Hotels &amp; Resorts and Hersha Hospitality Trust, from Outperform to Perform.
But apparently, merger fever has taken over with the acquisition of Hersha Hospitality, and investors seem to be disregarding the analysts and betting that other hotel REITs are grossly undervalued and primed for lucrative takeovers as well. If nothing else, those stocks clearly outperformed for one day.
Weekly REIT Report: REITs are one of the most misunderstood investment options, making it difficult for investors to spot incredible opportunities until it's too late. Benzinga's in-house real estate research team has been working hard to identify the greatest opportunities in today's market, which you can gain access to for free by signing up for the <a href="https://www.benzinga.com/money/reit-newsletter">Weekly REIT Report.</a>

Oppenheimer analyst Tyler Batory maintains Ashford (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AINC#AMEX">AINC</a>) with a Outperform and lowers the price target from $20 to $17.

Oppenheimer Maintains Outperform on Ashford, Lowers Price Target to $17

Ashford (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AINC#AMEX">AINC</a>) reported quarterly earnings of $1.57 per share which missed the analyst consensus estimate of $1.73 by 9.25 percent. This is a 28.96 percent decrease over earnings of $2.21 per share from the same period last year. The company reported quarterly sales of $192.71 million which beat the analyst consensus estimate of $181.71 million by 6.05 percent. This is a 15.08 percent increase over sales of $167.45 million the same period last year.

Ashford Q2 Adj EPS $1.57 Misses $1.73 Estimate, Sales $192.71M Beat $181.71M Estimate

<h3>Gainers</h3>
<ul>
<li>QualTek Services Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qtek#NASDAQ">QTEK</a>) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.</li>
<li>T2 Biosystems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttoo#NASDAQ">TTOO</a>) shares climbed 99.4% to $0.1886 after the company reported second largest sepsis-driven instrument sale in company history.</li>
<li>Aclarion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acon#NASDAQ">ACON</a>) climbed 69% to $1.0430 after the company announced a commercial agreement with the London Clinic and London Spine Clinic</li>
<li>Arlington Asset Investment Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aaic#NASDAQ">AAIC</a>) shares gained 50.1% to $4.1285 after Ellington Financial announced plans to acquire the company.</li>
<li>GreenLight Biosciences Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grna#NASDAQ">GRNA</a>) rose 37.8% to $0.2750 after the company announced it entered into a definitive agreement to be acquired by a group of buyers led by Fall Line Capital in an all-cash transaction valuing the company at approximately $45.5 million.</li>
<li>Equitrans Midstream Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etrn#NYSE">ETRN</a>) gained 37.4% to $8.35 after RBC Capital upgraded the stock from Sector Perform to Outperform and raised its price target from $7 to $10.</li>
<li>GD Culture Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdc#NASDAQ">GDC</a>) gained 31.3% to $5.83.</li>
<li>Atento S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atto#NYSE">ATTO</a>) shares surged 30.6% to $1.91 after gaining 8% on Friday.</li>
<li>Monopar Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnpr#NASDAQ">MNPR</a>) rose 30% to $1.1726.</li>
<li>Babylon Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbln#NASDAQ">BBLN</a>) surged 25.6% to $0.66.</li>
<li>PyroGenesis Canada Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pyr#NASDAQ">PYR</a>) gained 24.6% to $0.8328.</li>
<li>Ideanomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idex#NASDAQ">IDEX</a>) rose 22.6% to $0.0466.</li>
<li>Taro Pharmaceutical Industries Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/taro#NYSE">TARO</a>) surged 22.5% to $36.01.</li>
<li>Fanhua Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fanh#NASDAQ">FANH</a>) climbed 18.8% to $7.69 following first-quarter results.</li>
<li>Ashford Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ainc#NYSE">AINC</a>) rose 17.6% to $10.89.</li>
<li>Virios Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/viri#NASDAQ">VIRI</a>) gained 17.4% to $1.69. Virios Therapeutics recently regained compliance with Nasdaq minimum bid price requirement.</li>
<li>mCloud Technologies Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcld#NASDAQ">MCLD</a>) jumped 14.6% to $0.6150. mCloud Technologies recently formed a special committee for the purpose of exploring strategic alternatives.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iova#NASDAQ">IOVA</a>) rose 14.5% to $8.65 after the company reported the FDA acceptance of the Biologics License Application of lifileucel for the treatment of advanced melanoma.</li>
<li>UP Fintech Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tigr#NASDAQ">TIGR</a>) gained 13% to $2.9250 following better-than-expected quarterly results.</li>
<li>C3.ai, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ai#NYSE">AI</a>) shares climbed 12.3% to $37.03. The stock appears to be moving in anticipation of the company&#39;s quarterly results, which are due after the close Wednesday.</li>
<li>Riot Platforms, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) gained 12.3% to $12.26.</li>
<li>ChargePoint Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chpt#NASDAQ">CHPT</a>) climbed 12.2% to $9.52 after B of A Securities upgraded the stock from Neutral to Buy.</li>
<li>Wearable Devices Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlds#NASDAQ">WLDS</a>) shares rose 11.3% to $1.3020 after dropping 17% on Friday. Wearable Devices recently announced its Mudra Band for Apple Watch is available for preorder.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kc#NASDAQ">KC</a>) gained 11% to $4.2050. Kingsoft Cloud recently said first-quarter FY23 earnings missed estimates.</li>
<li>Nexters Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdev#NASDAQ">GDEV</a>) climbed 9.9% to $7.50.</li>
<li>United Homes Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uhg#NASDAQ">UHG</a>) rose 9.9% to $11.50.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) gained 8% to $61.46 after Atlantic Equities upgraded the stock from Neutral to Overweight and announced a $70 price target.</li>
<li>Broadcom Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avgo#NASDAQ">AVGO</a>) climbed 6.7% to $867.42. Several analysts, including, Keybanc, Evercore ISI Group and BMO Capital raised their price targets on the stock.</li>
<li>NVIDIA Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>) gained 5.3% to $409.94 after the company announced it would build the Israel-1 generative AI cloud supercomputer. The stock is also trading higher on continued upward AI momentum following the company&#39;s Q1 results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Smart for Life, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smfl#NASDAQ">SMFL</a>) shares fell 36.6% to $1.3750. Smart for Life reported exercise of warrants for $4.5 million in gross proceeds.</li>
<li>Applied UV, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auvi#NASDAQ">AUVI</a>) dropped 33% to $0.3751. Applied UV reported a 1-for-5 reverse stock split.</li>
<li>SeqLL Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sql#NASDAQ">SQL</a>) fell 26.8% to $0.38. SeqLL entered into definitive merger agreement with Lyneer Staffing Solutions and Atlantic Acquisition Corp.</li>
<li>D-Wave Quantum Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/qbts#NYSE">QBTS</a>) dropped 21.5% to $1.3105.</li>
<li>Oncorus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oncr#NASDAQ">ONCR</a>) fell 20.4% to $0.1750 after jumping 10% on Friday. Oncorus recently posted a narrower-than-expected quarterly loss.</li>
<li>Bright Health Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhg#NASDAQ">BHG</a>) fell 18.3% to $9.61. RBC Capital maintained Bright Health with a Sector Perform and lowered the price target from $80 to $13.</li>
<li>Beamr Imaging Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bmr#NASDAQ">BMR</a>) dropped 17.3% to $3.34.</li>
<li>Unique Fabricating, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ufab#NASDAQ">UFAB</a>) dropped 16.8% to $0.2108.</li>
<li>Presto Automation Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prst#NASDAQ">PRST</a>) fell 16.7% to $2.99 after jumping 64% on Friday. Presto Automation recently entered into commitments for an $10 million common equity pipe.</li>
<li>TScan Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcrx#NASDAQ">TCRX</a>) shares fell 16.5% to $2.6646 after jumping 31% on Friday. TScan Therapeutics raised $140 million via secondary stock offering of 23 million at $2 per share and 47 million pre-funded warrants at $2 per share.</li>
<li>9 Meters Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmtr#NASDAQ">NMTR</a>) dropped 16.2% to $0.6708. 9 Meters Biopharma announced management change and issued a clinical update on vurolenatide in patients with short bowel syndrome.</li>
<li>Enveric Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/envb#NASDAQ">ENVB</a>) dropped 15.5% to $3.6472.</li>
<li>Allarity Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/allr#NASDAQ">ALLR</a>) fell 14.7% to $0.2670 after declining 9% on Friday.</li>
<li>Appreciate Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfr#NASDAQ">SFR</a>) shares dropped 11.7% to $0.2820 after jumping around 60% on Friday.</li>
<li>IronNet, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/irnt#NYSE">IRNT</a>) shares dropped 11.4% to $0.2320 after climbing 33% on Friday. IronNet 13G Filing showed 3i, LP increased stake in the company to 9.99%.</li>
<li>Atea Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avir#NASDAQ">AVIR</a>) dipped 10.6% to $4.18. Atea Pharmaceuticals&#39; board unanimously rejected unsolicited proposal from Tang Capital Partners&#39; Affiliate, Concentra Biosciences.</li>
<li>HUTCHMED (China) Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcm#NASDAQ">HCM</a>) fell 9.9% to $12.06.</li>
<li>Seelos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seel#NASDAQ">SEEL</a>) fell 9.3% to $0.8419. On May 23, Nasdaq provided notice to Seelos Therapeutics that it has not regained compliance with rule 5550(A)(2).</li>
<li>Sana Biotechnology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sana#NASDAQ">SANA</a>) dropped 9% to $5.72.</li>
<li>Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) shares declined 8.3% to $2.9150. Lexicon Pharmaceuticals reported the FDA approval of INPEFA for the treatment of heart failure..</li>
<li>Weibo Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wb#NASDAQ">WB</a>) fell 8.2% to $14.03.</li>
<li>Skyline Champion Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sky#NYSE">SKY</a>) dropped 7.6% to $59.61 after the company reported mixed Q4 financial results.</li>
<li>Comerica Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cma#NYSE">CMA</a>) fell 6.8% to $36.34.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/05/32593583/top-5-health-care-stocks-that-could-blast-off-in-may"> Top 5 Health Care Stocks That Could Blast Off In May </a>

Intraday Update

AAIC

ACON

ALLR

ATTO

AUVI

AVIR

BBLN

CHPT

COIN

ENVB

ETRN

FANH

GDEV

GRNA

IDEX

IOVA

IRNT

LXRX

MCLD

MNPR

NMTR

NVDA

ONCR

PRST

QBTS

QTEK

RIOT

SANA

SEEL

SMFL

TARO

TCRX

TIGR

TTOO

UFAB

VIRI

WLDS

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Oppenheimer analyst Tyler Batory maintains Ashford (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AINC#AMEX">AINC</a>) with a Outperform and lowers the price target from $24 to $20.

Oppenheimer Maintains Outperform on Ashford, Lowers Price Target to $20

<h3>Gainers</h3>
<ul>
<li>Edoc Acquisition Corp. - Right (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADOCR#NASDAQ">ADOCR</a>) stock moved upwards by 40.8% to $0.2 during Friday's regular session. </li>
<li>Oxbridge Re Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXBR#NASDAQ">OXBR</a>) stock increased by 10.71% to $1.4. The market value of their outstanding shares is at $8.1 million. </li>
<li>Westwood Holdings Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHG#NYSE">WHG</a>) stock moved upwards by 9.71% to $11.41. The company's market cap stands at $105.4 million. </li>
<li>Oak Valley (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OVLY#NASDAQ">OVLY</a>) shares rose 7.87% to $26.29. The market value of their outstanding shares is at $217.7 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Greenhill &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHL#NYSE">GHL</a>) shares moved upwards by 7.85% to $7.75. Greenhill &amp; Co's stock is trading at a volume of 80.9K shares as of 13:30 EST. This is 99.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $141.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Reliance Global Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELI#NASDAQ">RELI</a>) stock decreased by 14.0% to $3.75 during Friday's regular session. Trading volume for Reliance Global Group's stock is 65.8K as of 13:30 EST. This is 64.6% of its average full-day volume over the last 100 days. The company's market cap stands at $5.8 million. </li>
<li>Marpai (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRAI#NASDAQ">MRAI</a>) shares fell 9.2% to $0.82. Marpai's stock is trading at a volume of 659.9K shares as of 13:30 EST. This is 47.2% of its average full-day volume over the last 100 days. The company's market cap stands at $23.7 million. </li>
<li>WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) shares decreased by 9.14% to $57.57. Trading volume for this security as of 13:30 EST is 4.0 million, which is 259.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $15.1 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>Katapult Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPLT#NASDAQ">KPLT</a>) stock decreased by 9.03% to $0.46. Trading volume for Katapult Holdings's stock is 88.2K as of 13:30 EST. This is 39.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $46.1 million. </li>
<li>CapStar Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTR#NASDAQ">CSTR</a>) shares fell 8.72% to $13.4. Trading volume for CapStar Finl Hldgs's stock is 123.0K as of 13:30 EST. This is 171.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $288.8 million. As per the press release, Q1 earnings came out today. </li>
<li>Ashford (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AINC#AMEX">AINC</a>) shares declined by 8.71% to $9.65. The market value of their outstanding shares is at $30.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADOCR

CSTR

KPLT

MRAI

OVLY

OXBR

RELI

11 Financials Stocks Moving In Friday's Intraday Session

B. Riley Securities analyst Bryan Maher maintains Ashford (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AINC#AMEX">AINC</a>) with a Neutral and lowers the price target from $18 to $14.

B. Riley Securities Maintains Neutral on Ashford, Lowers Price Target to $14

INSPIRE, a global event solutions company owned by Ashford Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AINC#NYSE">AINC</a>), is pleased to announce the appointment of&nbsp;Sayi Puligandla&nbsp;as Chief Operating Officer.
DALLAS,&nbsp;Feb. 7, 2023&nbsp;/PRNewswire-PRWeb/ -- INSPIRE, a global event solutions company owned by Ashford Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AINC#NYSE">AINC</a>), is pleased to announce the appointment of&nbsp;Sayi Puligandla&nbsp;as Chief Operating Officer.
In this position, Puligandla will oversee human resources, hospitality operations, information technology, and other projects to support the entire organization.
Puligandla brings to INSPIRE an extensive background in the hospitality industry and valuable experience in data, analytics, and building efficient operational units for accelerated growth. He was an executive vice president and a founding member of Nor1 (acquired by Oracle in 2020), a known pioneer and industry leader in hospitality upsell technology, where he architected and developed the analytics and BI infrastructure that paved the way for Nor1&#39;s upsell science.
Upon Oracle&#39;s acquisition of Nor1 in 2020, Sayi continued managing all aspects of Nor1&#39;s Global Gaming business as its Senior Director, as well as Business Development and Strategic Account Management for all Nor1&#39;s Global Accounts which included several of the ten largest hotel chains.
&quot;Sayi is incredibly talented and a proven leader. His unparalleled background and expertise will propel us toward our goals and ensure we achieve individualized, valuable solutions for our clients,&quot; said&nbsp;Chuck Bauman, CEO of INSPIRE.
For more information on INSPIRE, please visit the&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3777318-1&amp;h=1208699697&amp;u=http%3A%2F%2Fwww.inspiresolutions.com%2F&amp;a=website" target="_blank">website</a>.

Management

INSPIRE Announces The Appointment Of Sayi Puligandla As Chief Operating Officer

Ashford (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AINC#AMEX">AINC</a>) reported quarterly earnings of $1.48 per share which beat the analyst consensus estimate of $1.35 by 9.63 percent. This is a 33.33 percent increase over earnings of $1.11 per share from the same period last year. The company reported quarterly sales of $164.61 million which beat the analyst consensus estimate of $148.20 million by 11.07 percent. This is a 60.82 percent increase over sales of $102.36 million the same period last year.

Ashford Q3 EPS $1.48 Beats $1.35 Estimate, Sales $164.61M Beat $148.20M Estimate

Oppenheimer analyst Tyler Batory maintained a Buy rating on Ashford (AINC – Research Report) today and set a price target of $14.00. The company's ...

Oppenheimer Keeps Their Buy Rating on Ashford (AINC)

Ashford says compliance plan accepted by NYSE American

Ashford Non-GAAP EPS of $1.02, revenue of $97.4M

Ashford Inc. (AINC) Q4 2023 Earnings Call Transcript

Ashford Inc (AINC) just unveiled an update. Ashford Inc. recently conducted its fourth-quarter earnings conference call, discussing financial resul...

Ashford Inc Discusses Q4 Earnings and Regulatory Distinctions

Ashford Inc (AINC) has disclosed a new risk, in the Costs category. Ashford Inc.'s foray into the insurance sector through Warwick reveals a signif...

Ashford Inc.'s Bold Move: Venturing Into Insurance with Warwick Amid High Risks and Regulations

Ashford approves plan to terminate registration of its common stock

Hut 8, Cipher Mining among financial movers

XTIA, TPET and GSIT among mid-day movers

An update from Ashford Inc (AINC) is now available. J. Robison Hays, III, the Senior Managing Director and CEO of Ashford Inc. and Ashford Hospital...

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Ashford Stock (AMEX:AINC), Short Interest Report

People Also Watch